Hypertension

Article	Citations
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association	211
Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension	191
Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018	178
Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary	173
Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness	145
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor	142
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease	135
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension	135
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association	114
Early and Supernormal Vascular Aging	112
Evaluation of the Accuracy of Cuffless Blood Pressure Measurement Devices: Challenges and Proposals	103
Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association	96
Association of Cardiovascular Risk Factors and Lifestyle Behaviors With Hypertension	95
Antihypertensive Drugs and COVID-19 Risk	94
Urate, Blood Pressure, and Cardiovascular Disease	93
Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine	91
Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020	89
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients	87
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study	85
Microbial Peer Pressure	81
Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk	79
Hypertension, Neurovascular Dysfunction, and Cognitive Impairment	76
Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease	74
Epithelial Sodium Channel and Salt-Sensitive Hypertension	73
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study	72

Blood Pressure and Risk of Cardiovascular Disease in UK Biobank	71
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk	69
Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association	69
Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-Analysis	69
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors	67
Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association	67
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk	64
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing	64
Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension	64
Circadian Rhythm, Clock Genes, and Hypertension: Recent Advances in Hypertension	63
Hypertension, Prehypertension, and Hypertension Control	63
Hypertension Control in the United States 2009 to 2018: Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups	62
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination	62
Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses	61
Worldwide Trends in Prevalence, Mortality, and Disability-Adjusted Life Years for Hypertensive Heart Disease From 1990 to 2017	60
Role of Klotho in the Development of Essential Hypertension	60
Aldosterone as a Mediator of Cardiovascular Damage	60
Arterial Stiffness and Long-Term Risk of Health Outcomes: The Framingham Heart Study	60
Aortic Pulse Wave Velocity Predicts Cardiovascular Events and Mortality in Patients Undergoing Coronary Angiography	60
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries	60
Racial Disparities in Cardiovascular Complications With Pregnancy-Induced Hypertension in the United States	59
Piezo1-Mediated Mechanotransduction Promotes Cardiac Hypertrophy by Impairing Calcium Homeostasis to Activate Calpain/Calcineurin Signaling	58
Data Sharing Under the General Data Protection Regulation	58
Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium	58
Gut Microbiome-Derived Metabolite Trimethylamine N-Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans	58
Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin System	57
Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism	56
Heart Failure in Women With Hypertensive Disorders of Pregnancy	56
Dietary Approaches to Stop Hypertension Dietary Intervention Improves Blood Pressure and Vascular Health in Youth With Elevated Blood Pressure	55
Short-Term Postpartum Blood Pressure Self-Management and Long-Term Blood Pressure Control: A Randomized Controlled Trial	55
Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice	54
Essential Hypertension Is Associated With Changes in Gut Microbial Metabolic Pathways: A Multisite Analysis of Ambulatory Blood Pressure	53
Upregulation of Piezo1 (Piezo Type Mechanosensitive Ion Channel Component 1) Enhances the Intracellular Free Calcium in Pulmonary Arterial Smooth Muscle Cells From Idiopathic Pulmonary Arterial Hypert	53
Reference Intervals for Brachial Artery Flow-Mediated Dilation and the Relation With Cardiovascular Risk Factors	53
Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?	53
Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease: Filling a Guidance Gap: A Scientific Statement From the American Heart Association	53
High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients	52
Association of Cumulative Systolic Blood Pressure With Long-Term Risk of Cardiovascular Disease and Healthy Longevity	52
Arterial Stiffness in Aging: Does It Have a Place in Clinical Practice?	51
Nocturnal Hypertension and Heart Failure: Mechanisms, Evidence, and New Treatments	51
Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis	51
Digital Therapeutics in Hypertension: Evidence and Perspectives	49
New Concept of Onco-Hypertension and Future Perspectives	49
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System	48
Cancer Therapy–Related Hypertension: A Scientific Statement From the American Heart Association	47
Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension	47
Microbiota Introduced to Germ-Free Rats Restores Vascular Contractility and Blood Pressure	47
Butyrate Regulates COVID-19–Relevant Genes in Gut Epithelial Organoids From Normotensive Rats	47
Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success	47
Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain	46

White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020	45
Trends in Worldwide Research in Hypertension Over the Period 1999–2018	45
Caspase-4/11–Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension	44
Gut Microbiota Profile Identifies Transition From Compensated Cardiac Hypertrophy to Heart Failure in Hypertensive Rats	44
Left Atrioventricular Coupling Index as a Prognostic Marker of Cardiovascular Events: The MESA Study	44
Effects of Arterial Stiffness and Carotid Intima-Media Thickness Progression on the Risk of Overweight/Obesity and Elevated Blood Pressure/Hypertension: a Cross-Lagged Cohort Study	44
Effect of Sleep Disturbances on Blood Pressure	44
Hypertension, Arterial Stiffness, and Diabetes: a Prospective Cohort Study	44
Obstructive Sleep Apnea–Induced Neurogenic Nocturnal Hypertension	43
Pediatric and Adult Ambulatory Blood Pressure Thresholds and Blood Pressure Load as Predictors of Left Ventricular Hypertrophy in Adolescents	43
The Association of Age at Diagnosis of Hypertension With Brain Structure and Incident Dementia in the UK Biobank	43
Developmental and Early Life Origins of Cardiometabolic Risk Factors	42
Immune System and Microvascular Remodeling in Humans	42
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension	42
Brain Functional Magnetic Resonance Imaging Highlights Altered Connections and Functional Networks in Patients With Hypertension	42
Blood Pressure Effects of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Adults	42
Genetics of Primary Aldosteronism	42
Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations	41
Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure	40
Associations Between Systolic Interarm Differences in Blood Pressure and Cardiovascular Disease Outcomes and Mortality	40
Single-Center Prospective Cohort Study on the Histopathology, Genotype, and Postsurgical Outcomes of Patients With Primary Aldosteronism	40
Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community	39
Independent Associations of Education, Intelligence, and Cognition With Hypertension and the Mediating Effects of Cardiometabolic Risk Factors: A Mendelian Randomization Study	39
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines	39
Myeloid Piezo1 Deletion Protects Renal Fibrosis by Restraining Macrophage Infiltration and Activation	39
Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling	38
Effect of Arterial Stiffness and Carotid Intima-Media Thickness Progression on the Risk of Dysglycemia, Insulin Resistance, and Dyslipidemia: a Temporal Causal Longitudinal Study	38
Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension	38
Effect and Acceptability of Mindfulness-Based Stress Reduction Program on Patients With Elevated Blood Pressure or Hypertension	38
Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):	37
Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma	37
Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People	37
Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection	36
Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study	36
Furosemide for Accelerated Recovery of Blood Pressure Postpartum in Women with a Hypertensive Disorder of Pregnancy	36
Association Between Periodontitis and Blood Pressure Highlighted in Systemically Healthy Individuals	36
Confounding Factors in Renal Denervation Trials	35
Prediction of Cardiovascular Events by Type I Central Systolic Blood Pressure	35
PlGF (Placental Growth Factor) Testing in Clinical Practice: Evidence From a Canadian Tertiary Maternity Referral Center	35
Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease	35
Inverse Association Between Riboflavin Intake and New-Onset Hypertension	35
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes	35
Markers of Focal and Diffuse Nonischemic Myocardial Fibrosis Are Associated With Adverse Cardiac Remodeling and Prognosis in Patients With Hypertension: The REMODEL Study	34
Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza	34
Dietary Carbohydrate Intake and New-Onset Hypertension: A Nationwide Cohort Study in China	34
Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation	34
Origins of Primary Hypertension in Children	34
Role of Extracellular Vesicles in the Pathogenesis of Vascular Damage	33
Per- and Polyfluoroalkyl Substances and Incident Hypertension in Multi-Racial/Ethnic Women: The Study of Women's Health Across the Nation	32
How to Improve Awareness, Treatment, and Control of Hypertension in Africa, and How to Reduce Its Consequences: A Call to Action From the World Hypertension League	32
Effects of Experimental Sleep Restriction on Ambulatory and Sleep Blood Pressure in Healthy Young Adults: A Randomized Crossover Study	32
Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension	31
Twenty-Four–Hour Urinary Sodium and Potassium Excretion and Their Associations With Blood Pressure Among Adults in China	31
Adherence to Antihypertensive Medication and Incident Cardiovascular Events in Young Adults With Hypertension	31
FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension	31
Percutaneous Intracoronary Delivery of Plasma Extracellular Vesicles Protects the Myocardium Against Ischemia-Reperfusion Injury in Canis	31
Do β-Blockers Cause Depression?	31
Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis	31
Pulse Pressure, Prognosis, and Influence of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction	30
Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop Report	30
Altered Airway Microbiota Composition in Patients With Pulmonary Hypertension	30
Cardiovascular Prognosis in Drug-Resistant Hypertension Stratified by 24-Hour Ambulatory Blood Pressure: The JAMP Study	30
The 2020 “WHO Technical Specifications for Automated Non-Invasive Blood Pressure Measuring Devices With Cuff”	30
Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin)	30
Aortic Stiffness, Central Blood Pressure, and Pulsatile Arterial Load Predict Future Thoracic Aortic Aneurysm Expansion	29
Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective	29
Neutrophil Extracellular Traps Promote the Development of Intracranial Aneurysm Rupture	29
Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?	29
Activation of Rac1-Mineralocorticoid Receptor Pathway Contributes to Renal Injury in Salt-Loaded db/db Mice	29
Site-1 Protease-Derived Soluble (Pro)Renin Receptor Contributes to Angiotensin II–Induced Hypertension in Mice	29
Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis	29
Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia	29
Oral Antihypertensives for Nonsevere Pregnancy Hypertension: Systematic Review, Network Meta- and Trial Sequential Analyses	29
Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts	28
Primary Cilia in Trophoblastic Cells	28
Pediatric Primary Hypertension: An Underrecognized Condition: A Scientific Statement From the American Heart Association	28
Association Between Hypertensive Disorders of Pregnancy and Dementia: a Systematic Review and Meta-Analysis	28
Racial and Ethnic Differences in Blood Pressure Among US Adults, 1999–2018	28
GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis	28
Systolic Blood Pressure and Mortality in Community-Dwelling Older Adults: Frailty as an Effect Modifier	28

Cardiovascular Health Profile at Age 25 Years in Adults Born Extremely Preterm or Extremely Low Birthweight	27
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction	27
Sympathetic Neural Overdrive, Aortic Stiffening, Endothelial Dysfunction, and Impaired Exercise Capacity in Severe COVID-19 Survivors: A Mid-Term Study of Cardiovascular Sequelae	27
Salt Sensitivity of Blood Pressure in Women	27
Association of Nap Frequency With Hypertension or Ischemic Stroke Supported by Prospective Cohort Data and Mendelian Randomization in Predominantly Middle-Aged European Subjects	27
Historical and Recent Changes in Maternal Mortality Due to Hypertensive Disorders in the United States, 1979 to 2018	27
Magnesium Supplementation Attenuates Pulmonary Hypertension via Regulation of Magnesium Transporters	27
Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart	27
New Noninvasive Methods to Evaluate Microvascular Structure and Function	27
Inorganic Nitrite Supplementation Improves Endothelial Function With Aging	27
Trophoblast-Derived Extracellular Vesicles Promote Preeclampsia by Regulating Macrophage Polarization	27
Uric Acid Expression in Carotid Atherosclerotic Plaque and Serum Uric Acid Are Associated With Cerebrovascular Events	27
Hypertension Burden and the Risk of New-Onset Atrial Fibrillation	26
Maternal Vascular Lesions in the Placenta Predict Vascular Impairments a Decade After Delivery	26
Primary Aldosteronism: Where Are We Now? Where to From Here?	26
IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice	26
Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Con Side of the Argument	26
Alcohol Intake and Blood Pressure Levels: A Dose-Response Meta-Analysis of Nonexperimental Cohort Studies	26
Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors	26
Multiple Social Vulnerabilities to Health Disparities and Hypertension and Death in the REGARDS Study	26
Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria	25
Arterial Hypertension in Women: State of the Art and Knowledge Gaps	25
Angiogenic Factors and Long-Term Cardiovascular Risk in Women That Developed Preeclampsia During Pregnancy	25
Longitudinal Changes of Input Impedance, Pulse Wave Velocity, and Wave Reflection in a Middle-Aged Population	25
Early-but Not Late-Onset Hypertension Is Related to Midlife Cognitive Function	25
First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension	25
COMP (Cartilage Oligomeric Matrix Protein), a Novel PIEZO1 Regulator That Controls Blood Pressure	25
Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure	25
Short-Chain Fatty Acid Receptors and Blood Pressure Regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021	25
Oxidation of Ryanodine Receptors Promotes Ca 2+ Leakage and Contributes to Right Ventricular Dysfunction in Pulmonary Hypertension	25
Occupational Physical Activity and New-Onset Hypertension: A Nationwide Cohort Study in China	25
Impact of the 2003 to 2018 Population Salt Intake Reduction Program in England	25
Noise and Air Pollution as Risk Factors for Hypertension: Part II—Pathophysiologic Insight	24
Circulating Maternal sFLT1 (Soluble fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse Model	24
From Normal Cognition to Cognitive Impairment and Dementia: Impact of Orthostatic Hypotension	24
Blood Pressure Management in Stroke	24
Immune Mechanisms of Dietary Salt-Induced Hypertension and Kidney Disease: Harry Goldblatt Award for Early Career Investigators 2020	24
Maternal Hypertension Increases Risk of Preeclampsia and Low Fetal Birthweight: Genetic Evidence From a Mendelian Randomization Study	24
Arteriosclerosis, Atherosclerosis, and Cardiovascular Health: Joint Relations to the Incidence of Cardiovascular Disease	24
Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue	24
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage	24
Effect of Antihypertensive Treatment on Cerebral Blood Flow in Older Adults: a Systematic Review and Meta-Analysis	24
Growing Heart Failure Burden of Hypertensive Heart Disease: A Call to Action	24
Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure	24
Long-Term Blood Pressure Variability and Risk of Cardiovascular Disease Events Among Community-Dwelling Elderly	24
Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease	24
Chronic Hypoxia in Ovine Pregnancy Recapitulates Physiological and Molecular Markers of Preeclampsia in the Mother, Placenta, and Offspring	24
Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling	24
Blood Pressure Determinants of Cerebral White Matter Hyperintensities and Microstructural Injury: UK Biobank Cohort Study	23
Hypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination	23
Proximal Tubule-Specific Deletion of Angiotensin II Type 1a Receptors in the Kidney Attenuates Circulating and Intratubular Angiotensin II–Induced Hypertension in PT- Agtr1a	23
Famine and Trajectories of Body Mass Index, Waist Circumference, and Blood Pressure in Two Generations: Results From the CHNS From 1993–2015	23
Central Ang II (Angiotensin II)-Mediated Sympathoexcitation	23
Role of Endothelial G Protein-Coupled Receptor Kinase 2 in Angioedema	23
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients	23
Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension	23
Dietary Pattern and Long-Term Effects of Particulate Matter on Blood Pressure: A Large Cross-Sectional Study in Chinese Adults	23
Cellular Senescence Contributes to Large Elastic Artery Stiffening and Endothelial Dysfunction With Aging: Amelioration With Senolytic Treatment	23
Twenty-Four–Hour Central (Aortic) Systolic Blood Pressure: Reference Values and Dipping Patterns in Untreated Individuals	23
Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year	23
DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation	22
Mean Arterial Pressure and Chronic Kidney Disease Progression in the CKiD Cohort	22
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study	22
Blood Pressure and Arterial Stiffness in Association With Aircraft Noise Exposure:Long-Term Observation and Potential Effect of COVID-19 Lockdown	22
Long-Term Blood Pressure Variability Increases Risks of Dementia and Cognitive Decline: A Meta-Analysis of Longitudinal Studies	22
Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong	22
Mesenchymal Stem/Stromal Cell–Derived Extracellular Vesicles for Chronic Kidney Disease: Are We There Yet?	22
Health Care Delivery Interventions for Hypertension Management in Underserved Populations in the United States: A Systematic Review	22
Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study	22
Pediatric Ambulatory Blood Pressure Classification: The Case for a Change	22
Mineralocorticoid Receptor Antagonist Use and Hard Renal Outcomes in Real-World Patients With Chronic Kidney Disease	22
Gut Microbiota and Host Plasma Metabolites in Association with Blood Pressure in Chinese Adults	22
Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia	22
Uric Acid and Risk of Cardiovascular Disease: A Question of Start and Finish	22
Visit-to-Visit Blood Pressure Variability and Longitudinal Tau Accumulation in Older Adults	22
Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension	22
KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated With a Worse Baseline Status and Better Recovery of Left Ventricular Remodeling and Diastolic Function	21
Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease	21
Pro Re Nata Antihypertensive Medications and Adverse Outcomes in Hospitalized Patients: A Propensity-Matched Cohort Study	21
Immune Checkpoint Inhibitors Do Not Increase Short-Term Risk of Hypertension in Cancer Patients: a Systematic Literature Review and Meta-Analysis	21
Noise and Air Pollution as Risk Factors for Hypertension: Part I—Epidemiology	21
Urinary Stress Hormones, Hypertension, and Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis	21
Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway	21
Hypertension Statistics for US Adults: An Open-Source Web Application for Analysis and Visualization of National Health and Nutrition Examination Survey Data	21
DNA Methylation-Reprogrammed Ang II (Angiotensin II) Type 1 Receptor-Early Growth Response Gene 1-Protein Kinase C ε Axis Underlies Vascular Hypercontractility in Antenatal Hypoxic Offspring	21
Sympathetic Regulation of the NCC (Sodium Chloride Cotransporter) in Dahl Salt–Sensitive Hypertension	21
Tumor Necrosis Factor Alpha-Mediated Inflammation and Remodeling of the Extracellular Matrix Underlies Aortic Stiffening Induced by the Common Chemotherapeutic Agent Doxorubicin	21
Blood Pressure Levels in Young Adulthood and Midlife Stroke Incidence in a Diverse Cohort	20
The Microsoft Research Aurora Project: Important Findings on Cuffless Blood Pressure Measurement	20
Mineralocorticoid Receptor Antagonists Cause Natriuresis in the Absence of Aldosterone	20
DP1 (Prostaglandin D 2 Receptor 1) Activation Protects Against Vascular Remodeling and Vascular Smooth Muscle Cell Transition to Myofibroblasts in Angiotensin II–Ind	20
Effects of Renal Denervation on Sympathetic Nerve Traffic and Correlates in Drug-Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-Analysis	20
Long-Term Impacts of Preeclampsia on the Cardiovascular System of Mother and Offspring	20
Clinical Impact of the Maximum Mean Value of Home Blood Pressure on Cardiovascular Outcomes: A Novel Indicator of Home Blood Pressure Variability	20
Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex	20